ArticleThe Journal of clinical investigation2020

Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.

Santiago Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.